452 filings
Page 8 of 23
6-K
0rwtudbxsb3 jdmo4
12 Apr 21
Current report (foreign)
4:43pm
6-K
5ogstntmf84n5ik
4 Mar 21
Current report (foreign)
5:22pm
6-K
6mnsb146f577fn7y67ok
25 Feb 21
Current report (foreign)
4:31pm
6-K
5i6jqb b9o19
2 Feb 21
Akari Therapeutics Adds Histamine Inhibitor Votucalis to Pipeline to treat Neuropathic Pain and Dermatological Disease
12:00am
EFFECT
ln3jk6 pt8a98d3nm
4 Jan 21
Notice of effectiveness
12:15am
CORRESP
wx827niopb 1ydhwv0x
30 Dec 20
Correspondence with SEC
12:00am
UPLOAD
w9y5m xrqfaaf
30 Dec 20
Letter from SEC
12:00am
F-3
bd630
23 Dec 20
Shelf registration (foreign)
5:22pm
6-K
dwb4txg0ehrrgrt6de
11 Dec 20
Current report (foreign)
4:20pm
6-K
dhgwc5vhc cibvg
11 Dec 20
Current report (foreign)
4:19pm
6-K
nvhmhdt oib
9 Dec 20
Current report (foreign)
4:15pm
6-K
tgr9t7hcm1
3 Dec 20
Current report (foreign)
4:37pm
6-K
eerpbmrr2iyt9714
16 Nov 20
This Document Is Important and Requires Your Immediate Attention
9:40am
6-K
hxnoi 15xvlnn9l
6 Oct 20
Akari Therapeutics Announces Further Clinical Trial Progress Using Nomacopan to Treat COVID-19 Pneumonia
9:28am
6-K
lk6vw8 qota8xz3hml4
1 Oct 20
Current report (foreign)
9:30am
EFFECT
gxwqmhdi
21 Sep 20
Notice of effectiveness
3:28pm
EFFECT
kf9aqsti
21 Sep 20
Notice of effectiveness
3:27pm
EFFECT
i2c55r70u n3ifako3rc
21 Sep 20
Notice of effectiveness
3:26pm
EFFECT
z7v9cv7xffq8o4
21 Sep 20
Notice of effectiveness
12:46pm
POS AM
wrvr6xjcl
16 Sep 20
Prospectus update (post-effective amendment)
12:00am